Wilmington Savings Fund Society’s Takeda Pharmaceutical TAK Stock Holding History

Wilmington Savings Fund Society’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.23K	Hold	326	–	–	﹤0.01%	1264
2026 Q1	$6.04K	Hold	326	–	–	﹤0.01%	1250
2025 Q4	$5.08K	Buy	+326	New	+$4.66K	﹤0.01%	1250
2025 Q3	–	Sell	-3,910	Closed	-$60.4K	–	1987
2025 Q2	$60.4K	Buy	3,910 +1,111	+40%	+$16.4K	﹤0.01%	1186
2025 Q1	$41.6K	Sell	2,799 -20	-0.7%	-$280	﹤0.01%	1251
2024 Q4	$37.3K	Hold	2,819	–	–	﹤0.01%	1316
2024 Q3	$40.1K	Buy	+2,819	New	+$40K	﹤0.01%	1270

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Wilmington Savings Fund Society's TAK Position: Q2 2026 in Review

Wilmington Savings Fund Society held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 326 shares worth $5.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Wilmington Savings Fund Society first reported a position in TAK in Q3 2024 and has held it in 7 quarters since. The position peaked at $60.4K in Q2 2025. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Wilmington Savings Fund Society held 326 shares of Takeda Pharmaceutical worth $5.23K as of Q2 2026.
Wilmington Savings Fund Society left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1264 holding.
Wilmington Savings Fund Society first reported a position in Takeda Pharmaceutical in Q3 2024 and has held it in 7 quarters since.
Wilmington Savings Fund Society's Takeda Pharmaceutical position peaked at $60.4K in Q2 2025.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.